‘Biosimilar’ development takes largest portion in pharmaceutical R&D expensess
A field with the largest pharmaceutical R&D expenses was turned out to be the biosimilar field.
The Korea Health Industry Development Institute announced through the recent ‘2014 Pharmaceutical Product/Medical Device R&D Status’ that the biosimilar field had the largest portion in the entire R&...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
